Clinical Trial Update: Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated adding sorafenib to standard frontline therapy in elderly patients with newly diagnosed acute myeloid leukemia. The study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: University Hospital Muenster | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED